Oslo ,4 January 2021 : Reference is made toNavamedic ASA's ("Navamedic " or the "Company") stock exchange announcement published on4 August 2020 regarding the completion of the transaction withACS Dobfar andInfoRLife for the acquisition of marketing authorisations for a series of antibiotics for hospital use in the Nordic region (the "Transaction"). The board of directors ofNavamedic has today, on4 January 2021 , pursuant to the authorisation granted to it by the extraordinary general meeting held on11 March 2020 , resolved to settle the first tranche of the purchase price in the Transaction for an amount ofNOK 19 million by issuance of 1,053,775 new shares toInfoRLife . The resolution to issue the 1,053,775 new shares entails an increase of the Company's share capital ofNOK 779,793.50 . The subscription price for the new shares isNOK 18.0304 per share, which corresponds to the volume weighted average trading price of theNavamedic shares from 24 January to6 February 2020 , being the 10 last trading days prior to, but not including,Navamedic's stock exchange announcement published on7 February 2020 . Following the registration of the share capital increase with theNorwegian Register ofBusiness Enterprises (Nw. Foretaksregisteret), the Company's new share capital is 12,095,788.40, divided into 16,345,660 shares, each with a par value ofNOK 0.74 . For further information, please contact:Kathrine Gamborg Andreassen , CEO,Navamedic Mobile: +47 951 78 680 E-mail: kathrine@navamedic.com Lars Hjarrand, CFO,Navamedic Mobile: +47 917 62 842 E-mail: lars.hjarrand@navamedic.com AboutNavamedic Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies.Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge.Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in theUK andGreece .Navamedic is headquartered inOslo, Norway , and listed on theOslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com This information is subject to the disclosure requirements pursuant to the issuer rules for Oslo Børs.
Click here for more information
© Oslo Bors ASA, source